Screen LibraryProstate cancer : a comprehensive perspective /
Saved in:
| Corporate Authors: | |
|---|---|
| Group Author: | |
| Published: |
Springer,
|
| Publisher Address: | London : |
| Publication Dates: | 2013. |
| Literature type: | eBook |
| Language: | English |
| Subjects: | |
| Online Access: |
http://dx.doi.org/10.1007/978-1-4471-2864-9 |
| Carrier Form: | 1 online resource (xxxi, 1141 p.) : ill. (some col.) |
| Bibliography: | Includes bibliographical references and index. |
| ISBN: |
9781447128649 (electronic bk.) 1447128648 (electronic bk.) |
| Index Number: | RC280 |
| CLC: | R737.25 |
| Contents: |
Part I: Basic Scientific Foundation -- Development, Applied and Surgical Anatomy of the Prostate -- Molecular Biology and Prostate Cancer -- Endocrine Mechanisms, Androgen Receptor and Carcinogenesis, and Hormone Escape -- Molecular Mechanisms of Castrate Resistant Prostate Cancer -- Immunologic Aspects of Prostate Cancer -- Stem Cells in Carcinogenesis of the Prostate -- Murine Models of Prostate Cancer -- Prostate Cancer and the Metabolic Syndrome -- Inflammation and Cancer of the Prostate -- HIV and Prostate Cancer -- Prostate Cancer Genetics -- Gene Expression Pro fi ling and Somatic Genome Changes -- The Proteomic Approach to Prostate Cancer -- Epigenetic Changes in Prostate Cancer -- Biomarkers of Potential Therapeutic Value -- Prostate Tissue Banking -- Molecular Imaging in Diagnostics -- Molecular Risk Profiling -- Premalignant Lesions of the Prostate -- The Pathology of Prostatic Carcinoma -- The Pathology of Non-epithelial Tumors of the Prostate -- Neuroendocrine Prostate Cancer -- Part II: Epidemiology, Screening, and Chemoprevention -- Epidemiology of Prostate Cancer -- Racial Disparities and the Global Picture -- Natural History of Prostate Cancer -- Population-based Health Systems as a Foundation for Prostate Cancer Control Research: The Cancer Research Network -- Screening for Prostate Cancer -- Next Generation Screening Tests -- Diet and Prostate Cancer: A Holistic Approach to Management -- Estrogens in Prostate Cancer -- Vitamin D and Prostate Cancer -- The Role of 5[a]-Reductase Inhibitors (5-ARIs) -- Other Pharmaceutical Agents in the Chemoprevention of Prostate Cancer -- Part III: Diagnosis and Staging -- Early Detection and Patient Risk Stratification in Prostate Cancer -- Tumor Markers -- Prostate Specific Membrane Antigen-Based Diagnostics -- Prostate Specific Membrane Antigen-Based Therapeutics -- Presentation and Symptomatology of Prostate Cancer -- The Role of Ultrasonography -- The Use of Magnetic Resonance Imaging in the Management of Prostate Cancer -- The Role of Functional Magnetic Resonance Imaging Techniques -- Prostate Biopsy -- The Staging of Prostate Cancer -- Nuclear Medicine in Prostate Cancer -- Nanotechnology and Prostate Cancer -- Part IV: Risk Assessment and Decision-Making Strategies for Localized Prostate Cancer -- Disease Risk Stratification -- Nomograms in Prostate Cancer -- Comparative Effectiveness of Treatment Alternatives for Localized Prostate Cancer -- Part V: Management of Localized Disease -- Radical Treatment for Localized Disease: An Overview of Options and Strategies for Decision Making -- Quality of Life and Management of Localized Disease -- Active Surveillance for Favorable-Risk Prostate Cancer -- Anesthesia for Robotic-Assisted Prostatectomy -- Retropubic Radical Prostatectomy: The Technique -- Retropubic Radical Prostatectomy: The Results -- Radical Perineal Prostatectomy -- Laparoscopic Radical Prostatectomy: The Technique -- Laparoscopic Radical Prostatectomy: The Results -- Robotic-Assisted Radical Prostatectomy: The Technique -- Lymph Node Dissection in Prostate Cancer Surgery -- External Beam Radiotherapy for Low-Risk Prostate Cancer -- Prostate Brachytherapy: Low Dose Rate -- Prostate Brachytherapy: High Dose Rate -- Intensity-Modulated Radiotherapy -- Proton Beam Therapy and Novel Radiotherapeutic Approaches to the Treatment of Prostate Cancer -- Prostate Cryotherapy -- Focal Therapies for Localized Prostate Cancer -- Part VI: Failure and Management of Recurrent, Locally Advanced, and Advanced Disease -- Biochemical Failure in Prostate Cancer -- The Phenomenon of PSA Bounce After Radiation Therapy -- Management of Locally Recurrent Disease -- Management of High-Risk/Locally Advanced Disease -- Radiotherapy Plus Hormonal Therapy -- Watchful Waiting in Advanced Prostate Cancer -- Androgen and Androgen Receptor-Directed Therapy as Initial Treatment for Prostate Cancer -- Hormone-Based Therapies for Castration-Resistant Prostate Cancer -- Toxicity of Androgen Deprivation Therapy in Hormone-Sensitive Prostate Cancer -- Chemotherapy and Novel Systemic Approaches in the Treatment of Metastatic Castration Resistant Prostate Cancer -- Immunotherapy -- Bone Health: Prevention of Skeletal-Related Events and Palliative Care -- Part VII: Outcomes and Complications After Treatment -- Assessment of Treatment Outcomes Following Prostate Cancer Therapy -- Urinary Incontinence -- Erectile Dysfunction -- Immediate/Early Surgical Complications -- Population-Based Outcomes Following Treatment of Clinically-Localized Prostate Cancer -- Management of Radiation Adverse Effects -- Management of Complications Following Minimally Invasive Prostate Cancer Therapy -- Part VIII: Management of Emergencies and Palliative Care -- Prostate Cancer Emergencies -- Management of Bone Metastases -- Pain Relief in Metastatic Cancer -- The Psychosocial Impact of Prostate Cancer -- Nursing Issues in Prostate Cancer. |